Page last updated: 2024-11-03

opc 12759 and Asthma

opc 12759 has been researched along with Asthma in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murakami, I1
Zhang, R1
Kubo, M1
Nagaoka, K1
Eguchi, E1
Ogino, K1
Gohil, P1
Thakkar, H1
Gohil, U1
Deshpande, S1

Other Studies

2 other studies available for opc 12759 and Asthma

ArticleYear
Rebamipide suppresses mite-induced asthmatic responses in NC/Nga mice.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Oct-15, Volume: 309, Issue:8

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Alanine; Allergens; Animals; Antigens, Dermatophagoides; Antioxidants;

2015
Preliminary studies on the effect of rebamipide against the trypsin and egg-albumin induced experimental model of asthma.
    Acta pharmaceutica (Zagreb, Croatia), 2011, Volume: 61, Issue:4

    Topics: Alanine; Animals; Asthma; Disease Models, Animal; Female; Histamine Release; Male; Mice; Ovalbumin;

2011